SCHEMBL26080586

SCHEMBL26080586

c1ccc(-c2cccc(-c3ccc(-c4nc(-c5cccc6c5sc5ccccc56)nc(-c5cccc6oc7ccccc7c56)n4)cc3)c2)cc1

nearest known ligand 0.42

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALOX5 P09917 1/20 0.42
PRKDC P78527 6/20 0.37
PLA2G2A P14555 3/20 0.35
PLA2G4A P47712 3/20 0.35
PIK3CD O00329 2/20 0.35
PIK3CB P42338 2/20 0.35
MAPT P10636 1/20 0.34
BRD4 O60885 1/20 0.33
PIK3CA P42336 1/20 0.33
MTOR P42345 1/20 0.33
PIK3CG P48736 1/20 0.33
KCNH2 Q12809 1/20 0.33
BRDT Q58F21 1/20 0.33
PLA2G10 O15496 1/20 0.33
PARP14 Q460N5 1/20 0.33
LIMK1 P53667 1/20 0.33
TERT O14746 1/20 0.32
PIM3 Q86V86 1/20 0.32
TNKS O95271 1/20 0.32
TNKS2 Q9H2K2 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL26080907 1.00 ALOX5 (0.42) ALOX5PRKDCPLA2G2APLA2G4APIK3CD
SCHEMBL23515891 0.97 ALOX5 (0.44) ALOX5PRKDCPLA2G2APLA2G4APIK3CD
SCHEMBL21425048 0.97 ALOX5 (0.46) ALOX5PRKDCPLA2G2APLA2G4APIK3CD
SCHEMBL19802823 0.96 ALOX5 (0.40) ALOX5PRKDCPLA2G2APLA2G4APIK3CD
SCHEMBL22876619 0.96 ALOX5 (0.40) ALOX5PRKDCPLA2G2APLA2G4APIK3CD
SCHEMBL25645765 0.96 ALOX5 (0.44) ALOX5PRKDCPLA2G2APLA2G4APIK3CD
SCHEMBL25645982 0.96 ALOX5 (0.47) ALOX5PRKDCPLA2G2APLA2G4APIK3CD
SCHEMBL19802836 0.95 ALOX5 (0.41) ALOX5PRKDCPLA2G2APLA2G4APIK3CD
SCHEMBL26080616 0.95 LIMK1 (0.37) ALOX5PRKDCPLA2G2APLA2G4APIK3CD
SCHEMBL25627732 0.95 PRKDC (0.43) ALOX5PRKDCPIK3CDPIK3CBMAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230312538-A1 HETEROCYCLIC COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE COMPRISING SAME LT MATERIALS CO., LTD. (KR) 2023-10-05 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230312538-A1 HETEROCYCLIC COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE COMPRISING SAME CRY1, CYP1A1, CYP1B1 ALOX5 579/4885PRKDC 4577/4885PLA2G2A 3794/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.